The role of fructose-1,6-bisphosphatase 1 on regulating the cancer progression and drug resistance

Abstract Fructose-1,6-bisphosphatase 1 (FBP1) is the enzyme that limits the process of gluconeogenesis as it facilitates the hydrolysis of fructose-1,6-bisphosphate(F-1,6-BP) to produce fructose-6-phosphate(F6P) and inorganic phosphate. Gluconeogenesis is the production of glucose from small carbohy...

Full description

Saved in:
Bibliographic Details
Main Authors: Mengmeng Wang, Xiaoju Huang, Dan Zhang, Yisan Liu, Pian Liu
Format: Article
Language:English
Published: Springer 2025-03-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-02112-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850094800677634048
author Mengmeng Wang
Xiaoju Huang
Dan Zhang
Yisan Liu
Pian Liu
author_facet Mengmeng Wang
Xiaoju Huang
Dan Zhang
Yisan Liu
Pian Liu
author_sort Mengmeng Wang
collection DOAJ
description Abstract Fructose-1,6-bisphosphatase 1 (FBP1) is the enzyme that limits the process of gluconeogenesis as it facilitates the hydrolysis of fructose-1,6-bisphosphate(F-1,6-BP) to produce fructose-6-phosphate(F6P) and inorganic phosphate. Gluconeogenesis is the production of glucose from small carbohydrate substrates. The gluconeogenic process is typically suppressed in cancer because it inhibits glycolysis. Apart from its involvement in cellular glucose metabolism, FBP1 also plays a role in gene transcription, mRNA translation and stability regulation, and the immune microenvironment of tumors. Because of its multifaceted functions, the mechanisms by which FBP1 is involved in tumor development are complex. Moreover, FBP1 deficiency is associated with radiation and chemotherapy resistance and poor prognosis in cancer patients. Restoration of FBP1 expression in cancer cells is expected to hold promise for cancer therapy. However, up to now few reviews have systematically summarized the important functional mechanisms of FBP1 in tumorigenesis and the small molecule compounds that restore FBP1 expression. Therefore, this article addresses the question “How does FBP1 contribute to cancer progression, and can targeting FBP1 be a potential therapeutic approach?” by summarizing the effects of FBP1 on cancer development and progression as well as its mediated drug resistance and the future clinical applications of potential small molecule modulators targeting FBP1.
format Article
id doaj-art-e9e48bf2c65542e8bf00fb530c719a12
institution DOAJ
issn 2730-6011
language English
publishDate 2025-03-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj-art-e9e48bf2c65542e8bf00fb530c719a122025-08-20T02:41:34ZengSpringerDiscover Oncology2730-60112025-03-0116111710.1007/s12672-025-02112-2The role of fructose-1,6-bisphosphatase 1 on regulating the cancer progression and drug resistanceMengmeng Wang0Xiaoju Huang1Dan Zhang2Yisan Liu3Pian Liu4Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Urology, People’s Hospital of CiliCancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Fructose-1,6-bisphosphatase 1 (FBP1) is the enzyme that limits the process of gluconeogenesis as it facilitates the hydrolysis of fructose-1,6-bisphosphate(F-1,6-BP) to produce fructose-6-phosphate(F6P) and inorganic phosphate. Gluconeogenesis is the production of glucose from small carbohydrate substrates. The gluconeogenic process is typically suppressed in cancer because it inhibits glycolysis. Apart from its involvement in cellular glucose metabolism, FBP1 also plays a role in gene transcription, mRNA translation and stability regulation, and the immune microenvironment of tumors. Because of its multifaceted functions, the mechanisms by which FBP1 is involved in tumor development are complex. Moreover, FBP1 deficiency is associated with radiation and chemotherapy resistance and poor prognosis in cancer patients. Restoration of FBP1 expression in cancer cells is expected to hold promise for cancer therapy. However, up to now few reviews have systematically summarized the important functional mechanisms of FBP1 in tumorigenesis and the small molecule compounds that restore FBP1 expression. Therefore, this article addresses the question “How does FBP1 contribute to cancer progression, and can targeting FBP1 be a potential therapeutic approach?” by summarizing the effects of FBP1 on cancer development and progression as well as its mediated drug resistance and the future clinical applications of potential small molecule modulators targeting FBP1.https://doi.org/10.1007/s12672-025-02112-2FBP1CancerDrug resistanceSmall molecule drugs
spellingShingle Mengmeng Wang
Xiaoju Huang
Dan Zhang
Yisan Liu
Pian Liu
The role of fructose-1,6-bisphosphatase 1 on regulating the cancer progression and drug resistance
Discover Oncology
FBP1
Cancer
Drug resistance
Small molecule drugs
title The role of fructose-1,6-bisphosphatase 1 on regulating the cancer progression and drug resistance
title_full The role of fructose-1,6-bisphosphatase 1 on regulating the cancer progression and drug resistance
title_fullStr The role of fructose-1,6-bisphosphatase 1 on regulating the cancer progression and drug resistance
title_full_unstemmed The role of fructose-1,6-bisphosphatase 1 on regulating the cancer progression and drug resistance
title_short The role of fructose-1,6-bisphosphatase 1 on regulating the cancer progression and drug resistance
title_sort role of fructose 1 6 bisphosphatase 1 on regulating the cancer progression and drug resistance
topic FBP1
Cancer
Drug resistance
Small molecule drugs
url https://doi.org/10.1007/s12672-025-02112-2
work_keys_str_mv AT mengmengwang theroleoffructose16bisphosphatase1onregulatingthecancerprogressionanddrugresistance
AT xiaojuhuang theroleoffructose16bisphosphatase1onregulatingthecancerprogressionanddrugresistance
AT danzhang theroleoffructose16bisphosphatase1onregulatingthecancerprogressionanddrugresistance
AT yisanliu theroleoffructose16bisphosphatase1onregulatingthecancerprogressionanddrugresistance
AT pianliu theroleoffructose16bisphosphatase1onregulatingthecancerprogressionanddrugresistance
AT mengmengwang roleoffructose16bisphosphatase1onregulatingthecancerprogressionanddrugresistance
AT xiaojuhuang roleoffructose16bisphosphatase1onregulatingthecancerprogressionanddrugresistance
AT danzhang roleoffructose16bisphosphatase1onregulatingthecancerprogressionanddrugresistance
AT yisanliu roleoffructose16bisphosphatase1onregulatingthecancerprogressionanddrugresistance
AT pianliu roleoffructose16bisphosphatase1onregulatingthecancerprogressionanddrugresistance